The Valley Desk

NCT01926028 · Interventional trial

Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis

Overall registry status Completed

Phase 1 · Phase 2

Conditions Vulvovaginal Candidiasis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov